HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

J Bara Selected Research

O-sialoglycoprotein endopeptidase

10/2000Tk, a new colon tumor-associated antigen resulting from altered O-glycosylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


J Bara Research Topics

Disease

3Neoplasms (Cancer)
04/2004 - 10/2000
3Carcinoma (Carcinomatosis)
02/2004 - 01/2000
2Prostatic Neoplasms (Prostate Cancer)
02/2004 - 02/2003
2Colorectal Neoplasms (Colorectal Cancer)
05/2003 - 10/2000
1Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid)
10/2004
1Adenoma (Adenomas)
04/2004
1Conjunctival Diseases
12/2003
1Dry Eye Syndromes (Dry Eye Syndrome)
12/2003
1Pterygium
12/2003
1Aberrant Crypt Foci
05/2003
1Adenocarcinoma
02/2003
1Rosacea (Acne Rosacea)
10/2000
1Ovarian Cysts (Ovarian Cyst)
01/2000

Drug/Important Bio-Agent (IBA)

3MucinsIBA
02/2004 - 01/2000
2AntigensIBA
10/2004 - 10/2000
2Gastric MucinsIBA
04/2004 - 05/2003
2Monoclonal AntibodiesIBA
04/2004 - 01/2000
2HormonesIBA
02/2004 - 02/2003
1iodonitrotetrazolium (INT)IBA
04/2004
1RNA (Ribonucleic Acid)IBA
02/2004
1Messenger RNA (mRNA)IBA
12/2003
1trefoil factorIBA
12/2003
1Methylnitronitrosoguanidine (MNNG)IBA
05/2003
1Guanidine (Guanidine Nitrate)FDA Link
05/2003
1AntibodiesIBA
10/2000
1PolysaccharidesIBA
10/2000
1Tumor Viral Antigens (Large T Antigen)IBA
10/2000
1O-sialoglycoprotein endopeptidaseIBA
10/2000
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2000
1HLA-DR Antigens (HLA-DR)IBA
10/2000
1Muramidase (Lysozyme)IBA
01/2000

Therapy/Procedure

2Heterologous Transplantation (Xenotransplantation)
02/2004 - 02/2003
1Therapeutics
02/2003
1Immunotherapy
10/2000